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Internal medicine patients are mostly elderly; they have multiple co-morbidities, which are usually chronic, rather than self-limiting or acute
diseases. Neither administrative indicators nor co-morbidity indexes, though validated in elderly patients, are able to completely define these
“complex” patients or to allow physicians to correctly “cope” with them. For the complex patients found in internal medicine wards, internists
need not only to find the best diagnosis and treatment, but also to apply a complex intervention (i.e., a comprehensive assessment and both
continuous and multi-disciplinary care) in order to maintain their health and ability to function and to prevent or delay disability, frailty, and
displacement from home and community. The aim of this review is to underscore the differences between the concepts of co-morbidity and
complexity, to discuss instruments for their measurement, and to highlight related implications, areas of uncertainty, and the responsibilities of
internists in the assessment and management of inpatients of their wards. The conclusion we come to is that it is mandatory to shift from a
finance/administrative-based management system to a clinical process model (clinical governance) driven by the quality of themedical outcome
and the cost of achieving that outcome. From a “complexity theory” standpoint, patient-centered care and collaboration can be seen as simple
rules that guide desirable behaviors in a complex system. By exploring the real complexity of our patients, we exercise the holistic,
anthropologic medicine of the person that is internal medicine.
© 2007 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.Keywords: Co-morbidity; Internal medicine; Complexity; Elderly
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Internal medicine patients are mostly elderly [1] and have
multiple co-morbidities, owing to the progressive and chronic
nature of their diseases. Internal medicine has been defined as
“the specialty of complexity” [2–4]. The aim of this review is
to underscore the differences between the concepts of co-
morbidity and complexity, to discuss instruments for their
measurement, and to highlight related implications, areas of
uncertainty, and the responsibilities of internists in the
assessment and management of inpatients of their wards.
2. The concept of co-morbidity
2.1. Definition of co-morbidity
A simple definition of co-morbidity is “the concurrent
existence and occurrence of two ormore medically diagnosed
diseases in the same individual, with the diagnosis of each
contributing disease based on established, widely recognized
criteria” [5,6]. A co-morbidity, as a pre-existing secondary
diagnosis of the admitted patient, differs from a complication,
a condition acquired during a hospital stay [7]. Co-
morbidities are serious medical conditions that are not
directly related to the primary diagnosis itself but that involve
any other major organ system. These are usually chronic,
rather than self-limiting or acute and easily treated conditions.
Co-morbidity should not be regarded as the sum of a number
of diseases or as the coexistence of more than one disease
(multi-morbidity) in the same patient. Multi-morbidity is the
“co-occurrence of two or more diseases within one person,
without defining an index disease” [8]; it refers to the total
burden of all concurrently occurring pathological processes
(clinical and sub-clinical) that are intrinsic to the individual
and excludes socioeconomic factors, lifestyle factors, andaccess to health care; impairment is included, while disability,
which is dependent on the environment, is excluded. Because
of the decision-making that must follow, co-morbidity is
defined by establishing a hierarchy and relationships (e.g., in
drug–drug interactions or in selecting priorities) existing in
those situations.
2.2. Epidemiological data
Increasing numbers of people are found to have two or
more diseases at the same time, and the prevalence of multi-
morbidity increases as one ages [9]. Patients with three or
more chronic diseases make up half of the population above
65 years of age [10]. Some 35%, 47%, and 53% of men aged
60–69, 70–79, and 80 years and older, respectively, have two
or more chronic conditions, with higher levels among women
[11,12]. Only 16.4% of the non-institutionalized population
are free from a chronic health problem; 20.5% have a single
chronic condition and the remainder (63.1%) report two or
more chronic illnesses [13].
2.3. Measurement of co-morbidity
2.3.1. Four ways to approach co-morbidity
Studies of co-morbidity reveal that there is no consensus
about how the co-occurrence of diseases should be measured
[14,15].
A common approach is to count the number of diseases,
but the prevalence of co-morbidity estimated this way is
influenced by the number of chronic conditions included in
the adopted list. A common variant of the simple count is a
conditional count, i.e., the number of chronic diseases asso-
ciated with a particular index disease. For instance, using
arthritis as the index disease, Verbrugge and colleagues [16]
found that people over the age of 55 with arthritis experience,
Table 1
Attributes of a hospital's case mix
Attribute Meaning and features
Severity of Illness Refers to the extent of physiologic decompensation
or organ system loss of function
Risk of mortality Refers to the likelihood of dying
Prognosis Refers to the probable outcome of an illness,
including the likelihood of improvement or
deterioration in the severity of the illness, the
likelihood for recurrence, and the probable life span
Treatment difficulty Refers to patient management problems that a
particular illness presents to the health care provider.
Such management problems are associated with
illnesses without a clear pattern of symptoms,
illnesses requiring sophisticated and technically
difficult procedures, and illnesses requiring close
monitoring and supervision
Need for intervention Relates to the consequences, in terms of severity of
illness, that lack of immediate or continuing care
would produce
Resource intensity Refers to the relative volume and types of diagnostic,
therapeutic, and bed services used in the management
of a particular illness
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ditions among people without arthritis.
A second approach takes into account both the severity and
the number of co-morbid conditions.Most often, this approach
creates a cumulative index weighted by the severity of the
individual conditions or a co-morbidity severity score based on
themost severe condition. For example, in patients undergoing
total hip replacement, hospital complication rates are strongly
associated with the severity of co-morbidity; no patients with
level 4 co-morbid severity (uncontrolled, life-threatening
disease) are allowed to undergo hip fracture replacement [15].
A third approach to studying co-morbidity is to assess the
proportion of people who have pairs of co-morbid diseases.
Typically, this approach studies co-morbidity from the
perspective of an index disease. In the example of arthritis,
co-morbid pairs consider the proportion of those who haveTable 2
Features of understanding complex systems and models for decision-making
Category Features Example
Known Analytical/reductionist evidence-based care Most efficacious drug tr
uncomplicated angina





Complex Non-predictable, but potentially
understandable by pattern observation
Best practice complex c
for a person from a disa
population group who h
and depression, as well a
family problems
Chaotic Out of control, with no discernable order Managing alcoholic bing
chronic disease care for
angina, diabetes, chron
depression, with family
in a disadvantaged, remarthritis and a second co-morbid condition (e.g., arthritis and
high blood pressure).
A fourth approach to studying co-morbidity is to assess the
relative association between diseases by using a measure of
association. In addition to crude descriptive measures, odds
ratios and relative risks can be used to study co-morbidity,
whereas multi-morbidity can be studied using observed/
expected ratios, such as the odds ratio [8,17].
2.3.2. Co-morbidity indexes
Several indexes have been proposed to evaluate co-
morbidity in patient populations with complex health
situations [18–20]. Each includes a series of domains that
vary according to the authors' view of co-morbidity. These
indexes were validated under different conditions with
similar targets. Their validation fields limit their use and the
ability to extrapolate results. Only the CIRS, the Charlson
index, the Kaplan–Feinstein index, the Geriatric Index of Co-
morbidity (GIC), and the ICED have been validated and
applied to elderly patients. Among these, the CIRS appears to
be sufficiently reliable because it allows for a comprehensive
recording of all co-morbid diseases from the clinical
examination and medical file data [18] (Appendix).
3. The concept of complexity
The concept of complexity is not unequivocal. For
hospitalized patients, the term “case mix complexity” has
been used by clinicians and administrators to refer to a set of
multiple attributes that include, in addition to co-morbidity,
severity of illness, risk of dying, prognosis, treatment
difficulty, need for intervention, resource intensity, etc. Each
of these attributes has a very precise meaning that describes a
particular aspect of a hospital's case mix (Table 1).
Administrators and regulators usually use the concept of
case mix complexity to indicate that the patients treated
require more resources, which results in a higher cost of
providing care.Main referring models for clinical decision-making




Evidence-based medicine, clinical judgment, defining




s alcohol, legal, and
Clinical judgment, cost-effective analysis, ethical/
legal analysis, selection of priorities, coordination
e crises in complex
a person with
ic renal failure, and
and legal problems
ote population
Clinical judgment, cost-effective analysis, ethical/
legal analysis, selection of priorities, coordination,
charisma or “dictatorship”
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The concept of complexity lacks a precise definition.
Complexity is the quality of being intricate and compound. It
refers to the degree of complication of a system or of a system
component, determined by such factors as the number and
intricacy of interfaces, the number and intricacy of conditional
branches, the degree of nesting, and the types of data structures
[21]. Complexity is the property of a “real world” system that
is manifested in the inability of any one schematic model to
adequately capture all of its properties. Complexity science
suggests an alternative model in which illness (and health)
result from complex, dynamic, and unique interactions
between different components of the overall system [22].
According to these meanings, complexity in a patient involves
the intricate entanglement of two or more systems (e.g., body-
diseases, family-socioeconomic status, therapies).
3.2. Approaches to complex systems: the complexity theory
Approaches to understanding complex systems, developed
by Kurtz and Snowden [23], have been successfully applied
with frontline health care providers [24]. They categorize
activities on four levels of knowledge and organization, which
are described as “the known”, “the knowable”, “the complex”,
and “the chaotic”. Each is governed by a particular evidence
and decision-making mode (Table 2) [23,25].
Complexity theory is the study of systems characterized
by non-linear dynamics. It suggests that practices are
complex adaptive systems consisting of local agents whose
interactions lead to continually emerging novel behavior
[26]. Recent developments in medicine provide the physician
with newer approaches to understanding the scope of the
complex adaptive processes of medical decision-making
[27]. Change emerges as a result of interactions between
agents at a local level in the complex system and between the
system and its environment. The belief is that efforts to
change practice should be preceded by efforts to understandTable 3
Co-morbidity and complexity and their major health care implications [6]
The complex patient Implications
Co-morbidity — Assessment o
— High susceptib




Complexity — Slow recovery
The intricate entanglement of two or more systems
(e.g., body-diseases, family-socioeconomic status, therapies)
— High risk of m
— Minimizing d





— Need for a pr
— Fragmented, m
— Constant requ
— Frequent andit. The focus is on informally reviewing processes and
structures in a way that helps a team to have a sense as to what
works well and what could be improved.
3.3. Further variables for the “complex patient” concept:
disability and frailty
3.3.1. Disability
Although physical function is believed to be an important
predictor of outcomes in older people, it has seldom been
used to adjust for prognosis or case mix in evaluating
mortality rates or resource use. Activities of daily living
(ADL) functionmeasurement contains important information
about prognosis and case mix beyond that provided by
routine physiologic data and co-morbidities in hospitalized
patients. Prognostic and case mix adjustment methods may
be improved if they include measures of function as well as
routine physiologic measures and co-morbidity [28]. Limited
ADL (Barthel index on admission), pre-morbid disability,
and polypharmacy are the strongest predictive factors of
outcome, independent of diagnosis, in acute geriatric wards
[29]. The prognosis of older patients hospitalized in medical
intensive care units depends not only on their acute physio-
logical impairments, but also on a series of pre-existing
conditions, such as loss of functional independence, severe
and moderate cognitive impairment, and low BMI [30].
3.3.2. Frailty
Frailty is not easy to define. It is a condition with a high
risk of a negative outcome and a worsening quality of life that
is frequently associated with disability and socioeconomic
problems. Recalling the complexity concept, Rockwood et al.
defined frailty as “a vulnerable state of health, arising from
the complex interaction of medical and social problems,
resulting in a decreased ability to respond to stress, and
associated with a decline in functional performance” [31].
From a clinical perspective, it is characterized by a high
susceptibility to developing acute diseases, reduced motorf frailty–disability prone patients
ility to develop acute diseases, mostly expressed by atypical clinical pictures
tions in health status





of treatment and high risk of iatrogenic problems and adverse events
rug interactions, adverse drugs reactions, adverse outcomes, incompatibility,
)
ent
ioritization of treatment (“hierarchy” of priorities)
ulti-provider, multi-setting care
est for medical interventions
repeated hospitalizations and the need for continuous care
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diseases present, rapid fluctuations in health, a remarkable
tendency to develop complications (cascade events), and a
high risk of adverse events; slow recovery capacity, failure to
thrive, a constant request for medical interventions, frequent
and repeated hospitalizations and the need for continuous
care; and a high risk of mortality. The elusiveness of a
definition of frailty reflects not only the challenges in
defining a clinical syndrome where the exact etiology and
pathophysiology are unknown, but also the challenges of
defining the boundaries of a syndrome that has medical,
functional, and social components [32].
At the moment, we do not have a decisive and unequivocal
tool to evaluate frailty. Flugelman's index is based upon the
evaluation of seven parameters in hospitalized patients,
namely, mobility, sphincter control, mental competence,
feeding ability, presence of pressure sores, medical condition,
and family state. The sum of the scores of all parameters gives
the final prognostic index. This is a simple and relatively
accurate tool for assessing the prognosis of elderly patients. A
score of 17 or more indicates a poor prognosis [33]. Another
reliable and sensitive clinicalmeasure of frailty was introduced
by Jones et al. in 2004 [34]. Their frailty index is based upon a
multi-dimensional comprehensive assessment in ten standard
domains: cognitive status, mood and motivation, communi-
cation (vision, hearing, speech), mobility and balance, bowel
function, bladder function, ADLs and IADLs, nutrition, and
social resources 35. Mitnitski et al. examined the relationship
between a frailty index and age and mortality. In their studies,
they took into account a range of co-morbid illnesses,
measures of disability, and social and psychological issues in
their frailty index, a measure converting the percentage of
deficits present or absent in a particular patient into an index
score that varies between 0 and 1, with 0 reflecting no deficits
and 1 the presence of all deficits [36,37].
3.4. Consequences of co-morbidity and complexity
Co-morbidity and complexity underlie demographic, ge-
netic, biological, lifestyle, and related risk factors, as well as
physical, psychological, economic, and social causes. Their
consequences are reflected in mortality, functional status and
disability, quality of life, treatment, complications, use of health
services, length of hospital stay (LOS), hospital charges, and
quality and costs of care [14,38–41]. The increase in costs with
increasing co-morbidity affects both primary and specialty care
[42]. Co-morbidity is a strong confounding factor, especially
for elderly patients with multiple diseases, in evaluating the
outcomes and the effectiveness of treatment, as well as in
choosing the best “tailored care” for a patient (Table 3).
4. The need for a comprehensive, multi-dimensional
assessment
Many studies describe benefits of a comprehensive
assessment of elderly patients by an interdisciplinary teamfollowed by multi-disciplinary intervention after discharge
[43]. A comprehensive geriatric assessment (CGA) allows
one to gain insight into the frail, elderly patient's condition. It
is a multi-dimensional, often interdisciplinary, diagnostic
process focused on determining a frail, elderly person's
medical, psychological, and functional capabilities in order to
develop a coordinated and integrated plan for treatment and
long-term follow-up [44–48]. The principal domains assessed
in all forms of geriatric assessment are functional ability,
physical health, cognitive and mental health, and the socio-
environmental situation. Standardized instruments include the
Katz ADL Scale and the Lawton IADL Scale for the
evaluation of functional ability: activities of daily living
(ADLs) and instrumental activities of daily living (IADLs); the
Tinetti Balance and Gait Evaluation, the Mini-Mental State
Examination, theGeriatricDepressionScale, and theHamilton
Depression Scale for cognitive and mental health. A socio-
environmental situation is difficult to quantify but includes the
social interaction network, available social support resources,
special needs, and environmental safety [49].
5. Administrative data do not reflect the complexity of
internal medicine patients
The usual hospital indicators are not able to reflect the
complexity of internal medicine patients' needs. Adminis-
trative data based on hospital discharge codes consistently
underestimate, or at least under-report, the presence of co-
morbid conditions [50–52]. The concept of a principal di-
agnosis is not transferable to internal medicine and general
practice. The range of problems encountered often crosses
multiple body systems and may include undiagnosed
symptoms, psychosocial and economic problems, or chronic
disease [53]. The original objective of diagnosis-related
groups (DRGs) was to develop a patient classification system
focused exclusively on resource intensity. Yet, the DRGs
system has many limitations. For example, it does not take
into account illness severity and complexity of the patient or
his/her social and living setting. The APR-DRGs (all patients
refined DRGs), a modification of the traditional DRGs, expand
the basic DRG structure by adding four subclasses to each
DRG. The four severity of illness subclasses and the four risk
of mortality subclasses are numbered sequentially from 1 to 4,
indicating respectively, minor, moderate, major, or extreme
severity of illness or risk of mortality. The underlying clinical
principle of APR-DRGs is that the severity of illness or risk of
mortality subclass of a patient is highly dependent on the
patient's underlying problems and that patients with a high
severity of illness or risk of mortality are usually characterized
bymultiple serious diseases or illnesses. In theAPR-DRGs, the
determination of the severity of illness and risk of mortality is
disease-specific. Thus, the significance attributed to compli-
cating or co-morbid conditions is dependent on the underlying
problem. Moreover, the APR-DRG system has been found to
be able to evaluate the clinical and functional impairment of
elderly inpatients, as properly assessed by the CGA [54].
364 R. Nardi et al. / European Journal of Internal Medicine 18 (2007) 359–3686. Clinical decision-making in complex conditions of
uncertainty
Complexity theory is based on understanding patterns that
are not predictable by traditional evidence and social
knowledge within a complex adaptive system [55]. Effective
clinical decision-making requires a holistic approach that
accepts unpredictability and builds on subtle, emergent forces
within the overall system [22]. Evidence-based care is based
upon known, knowable, and ideal experimental conditions.
Most clinical trials base their protocol exclusion criteria on co-
morbid conditions, often considered as “confounders”, thus
disqualifying and excluding “real” older patients. Complex
patients, who are excluded from randomized, controlled trials
andwho rarely fit into the standard care guidelines, become the
“grey zone”, requiring special, tailored treatments. Most
clinical practice guidelines (CPGs) do not take into account
or discuss their applicability for older patients with multiple
co-morbidities. This may compromise the ability to generalize
the results since the frail, older patients with significant co-
morbidities may have a different benefit-to-risk ratio for any
given intervention [56]. Physicians' poor adherence to
protocols and guidelines is well documented. Moreover,
CPGs and recommendations typically do not take into account
the incremental effects on regimen complexity. Adhering to
current CPGs in caring for an older person with several co-
morbidities may have undesirable effects, such as multi-
prescription, higher costs, and adverse drug–drug interactions
[57]. Complex patients often require special, expensive
treatments and procedures ordered by multiple physicians.
Care decisions are seldom well coordinated and communicat-
ed among the patient's multiple caregivers, which may result
in duplicate, unnecessary, or even inappropriate treatments and
tests. The typical result is higher costs and decreased patient
satisfaction. Moreover, the complex patient's illness is often
compounded by significant social or economic problems. In
this situation, clinical practice implies a certain degree of
uncertainty. Making a medical decision often involves
considering different factors that go beyond the field of
technical and scientific knowledge (family, social, economic
problems, etc.) and may demand an ethical analysis of the
decision, including cost-effective and legal considerations of
the outcomes. Any enthusiasm for evidence-based medicine
and related guidelines must be tempered with the knowledge
that they are fallible, particularly if applied to complex elderly
patients. They should not replace clinical judgment or previous
gold standard experience [58].
7. The importance of being a competent internist
Internists, often referred to as “doctors for adults”, provide
most of the medical care given to older patients, especially
those with serious chronic disease. They have to cope with
complicated clinical problems by being an efficient diagnos-
tician of complex diseases and they must also be skilled in
understanding and managing disorders of various organs andsystems. Their patients' high complexity, extreme instability,
and vulnerability call for management that comes from
extensive clinical expertise combined with “common sense”
and longstanding experience [59–62]. An internist should be
concerned with his patient's “whole health” status, and he
should include in his management all factors related to social,
behavioral, environmental, functional, and medical problems.
Internal medicine is a specialty derived from the 19th
century idea of clinical medicine; however, during the 20th
century it was broken down into several pieces of knowledge.
Reduced preconceptions of patient approach, a broad-based
clinical view for generating diagnostic hypotheses as opposed
to a biased-domain approach, the capability to manage
diagnostic and therapeutic complexity, and flexibility to
different epidemiological and organizational contexts are the
main characteristics required of internal medicine hospitalists
today in order to make suitable decisions in complex and
uncertain situations [63]. Other characteristics that are needed
to increase competence are: 1) optimization of critical
pathways based on a broad clinical view; 2) effective patient
global risk management; 3) better coordination of sub-
specialist support; and 4) better communication with primary
care providers to improve overall patient-case management
[64].
8. Managing complexity in the care of internal medicine
patients: conclusions
While the elderly make up the largest part of hospital
populations [1], “we are still practicing acute care medicine in
a world of chronic disease” [65,66]. Future hospital planning
for the elderly should target the 75+ age group because they
represent most of the frail elderly with complex problems and
multiple illnesses. The high burden of illness and frailty,
common among our growing population of older adults, often
results in fragmentation of care among providers and health
care systems, increasing the complexity and costs of caring
for these patients. To provide health care for older adults,
physicians must typically deliver long-term care for several
chronic and acute conditions and follow-up a wide variety of
clinical measures and interventions [67]. The single organ
system approach has its limitations in hospital care of frail
elderly patients. Pitfalls in diagnosis, investigation, and
management, including iatrogenesis and adverse drug
reactions, are prone to occur. It is not sufficient to identify
acute illnesses and medically deal with them in a narrowly
defined sense. The essence of management in our patients is
to embrace their complexity and needs for care. These
patients require a complex intervention (comprehensive
assessment, continuous and multidisciplinary care) in order
for them to maintain their health, function, and ability to play
a vital role in the life of their community, as well as to prevent
or delay disability, frailty, and displacement from home and
community [68]. No measure of case mix complexity can be
equally effective for all of the different aspects of case mix
complexity. Several health researchers have measured co-
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is still a need for better ways of measuring the health status of
individuals with complex disorders.
Complexity requires an understanding of patterns that are
not predictable by traditional evidence and social knowledge
within a complex adaptive system [69]. Complexity is the
science of the 21st century; we should not have to wait
decades to see it applied [70].We have to shift from a finance/
administrative-based management system to a clinical
process model (clinical governance) driven by the quality
of the medical outcome and by the cost of achieving that
outcome. From a complexity theory standpoint, patient-
centered care and collaboration can be seen as simple rules
that guide desirable behaviors in a complex system [71]. By
exploring the real complexity of our patients, we exercise the
holistic, anthropologic medicine of the person that is internal
medicine.
9. Learning points
• Co-morbidity is the concurrent existence and occurrence
of two or more medically diagnosed diseases in the same
individual, with the diagnosis of each contributing disease
based on established, widely recognized criteria.
• Complexity science suggests that illness (and health) result
from complex, dynamic, and unique interactions between
different components of the overall system. In a patient,
complexity involves the intricate entanglement of two or
more systems (e.g. body-diseases, family-socioeconomic
status, therapies).
• Complexity requires an understanding of patterns that are
not predictable by traditional evidence and social
knowledge; we have to shift from a finance/administra-
tive-based management system to a clinical process model
(clinical governance) driven by the quality of the medical
outcome and by the cost of achieving that outcome.
• By exploring the real complexity of our patients, we
exercise holistic, anthropologic medicine of the person,
i.e., internal medicine.
Appendix A. The Charlson co-morbidity index
The best known and most frequently used index is the
Charlson co-morbidity index. It was developed in 1987, based
on 1-year mortality data from internal medicine patients
admitted to a single New York hospital and was initially
validated within a cohort of breast cancer patients. This index
was created to enhance prediction of 1-yearmortality, but it has
since been used to predict other health outcomes, such as
functional status. The Charlson scale is a list of 19 conditions
whose presence is associated with at least a 20% increased risk
of death. On the basis of these relative risks, each condition is
weighted from 1 to 6. The co-morbidity score reflects the
cumulative increased likelihood of 1-year mortality; the higher
the score, the more severe the burden of co-morbidity. This
method of classifying co-morbidity provides a simple, readilyapplicable, and valid method of estimating risk of death from
co-morbid disease for use in longitudinal studies [72].
However, the Charlson index was found to be limited in
recording the entirety of pathologies in old patients and in
patients with cognitive deficits [18].
Appendix B. Charlson’s alternative co-morbidity indexes
Roos et al. [73] quantified the effect of augmenting the
Charlson Index. They developed a co-morbidity algorithm
that does not use individual diagnoses directly in the co-
morbidity score calculation. The individual diagnoses
determine attribution to co-morbidity categories scored as
binary variables. This binary attribution within a co-
morbidity category limits the effect of complications in risk
adjustment. Deyo et al. [74] adapted a clinical co-morbidity
index that is useful in studies of disease outcome and resource
use employing an administrative database. Stukenborg et al.
[75] compared two co-morbidity indexes (Deyo and
Elixhauser methods) and concluded that the Elixhauser
index achieves better discrimination than the Deyo adapted
index. Sloan et al. [76] constructed an alternative, pharmacy-
based index (RxRisk-V) that provides a good description and
understanding of chronic disease burden of their treated
patients. Quan et al. [77] developed ICD-10 coding
algorithms to define Charlson and Elixhauser co-morbidities
in administrative data and to assess the performance of the
resulting algorithms. These newly developed co-morbidity
coding algorithms may outperform existing ICD-9-CM
coding algorithms.
Appendix C. The Greenfield Index of Coexisting Disease
(ICED)
The Index of Coexisting Disease (ICED) has a two-
dimensional structure, measuring disease severity and dis-
ability, which can be useful when mortality and disability
are the outcomes of interest [78,79]. This tool has two
subscales indicating the presence or absence of 15 disease
categories and, for each category, five levels of physiolog-
ical disease severity; moreover, it rates the severity of 11
functional impairments (e.g., respiratory, ambulation, con-
tinence) on three levels. Each scale is scored individually
and is then combined to give an overall rating: none, mild,
moderate, or severe co-morbidity. A major limitation of the
ICED is that it requires medical records and highly trained
reviewers who can follow complex decision rules in creating
the index.
Appendix D. The Geriatric Index of Co-morbidity (GIC)
The Geriatric Index of Co-morbidity (GIC) is a composite
score that takes into account both the number of diseases and
the occurrence of very severe diseases. It has been validated
in elderly disabled patients and is a good predictor of
mortality [80].
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(CIRS)
The Cumulative Illness Rating Scale (CIRS), originally
developed by Linn et al. [81], is a brief, comprehensive,
and reliable measure of a patient's health impairment. It
addresses all relevant body systems without using specific
diagnoses. CIRS appears to be sufficiently reliable because
it allows a comprehensive recording of all co-morbid
diseases from clinical examination and medical file data
[18,19]. An adaptation of CIRS is particularly interesting
for geriatric patients, the CIRS-Geriatric (CIRS-G). The
CIRS-G is aimed at a comprehensive recording of all the
co-morbid diseases of a patient. Its principle is to class co-
morbidities by organ system affected and to rate them
according to their severity from 1 to 5 (1=none; 2=mild;
3=moderate; 4=severe; 5=extremely severe). CIRS-G's
14 items are based on evaluation of: the cardiovascular-
respiratory system: (1) cardiac (heart only); (2) hyperten-
sion; (3) vascular (blood, blood vessels and cells, marrow,
spleen, lymphatics); (4) respiratory (lungs, bronchi, trachea
below the larynx); (5) EENT (eyes, ears, nose, throat,
larynx); gastrointestinal system (GI): (6) upper GI
(esophagus, stomach, duodenum, biliary and pancreatic
trees); (7) lower GI (intestines, hernias); (8) hepatic (liver
only); genitourinary system; (9) renal (kidneys only); (10)
other genito-urinary (ureters, bladder, urethra, prostate,
genitals); (11) musculo-skeletal–integumentary system
(muscle, bone, skin); (12) neurological (brain, spinal
cord, nerves); (13) endocrine-metabolic (includes diffuse
infections, poisonings); and (14) psychiatric (mental)/
behavioral. For each item, the degree of impairment is
described; for illnesses that cause impairment on more than
one of the items, more than one item must be rated; when
more than one illness occurs for a given item, it is the total
impairment from these illnesses that is rated. In the CIRS, a
“co-morbidity composite” (the number of items with a
rating of 3–4 or 5, excluding psychiatric) and an “illness
severity composite” [mean of points= (points for all items
except psychiatric/13)] are measured. In this way, two
parameters are obtained: the CIRS-IS (index severity), as
the mean of all single item scores, and the CIRS-CI (co-
morbidity index), as the number of single items with a score
of 3, 4, or 5.
Appendix F. Total Illness Burden Index (TIBI)
The TIBI uses patients' self-report of symptoms, and
diagnoses are made to determine not only the presence but
also the severity of co-morbidities in each of 16 body system
domains. This composite measure of symptoms, diagnoses,
and disease manifestations helps clinicians assess the
severity of illness for a particular patient. It can also be
used to evaluate the severity mix of patients in a clinician's
caseload, thereby enabling important comparisons of cost
and outcomes [79].Appendix G. Kaplan–Feinstein Index (KFI)— Adult
Co-morbidity Evaluation (ACE 27-modified KFI)
Developed from the study of co-morbidity in patients with
diabetes mellitus, the KFI has been used to study the impact of
co-morbidity in several cancers. Specific diseases and
conditions are classified into four groups–none, mild, mod-
erate, or severe–according to severity of organ decompensa-
tion and prognostic impact [82]. The index has been criticized
for being too complicated for routine use. Moreover, it does
not include several other important conditions, e.g., AIDS and
dementia. For these reasons, the KFI was modified with Ace
27, an adaptation from the Kaplan–Feinstein Index, larger in
terms of number of items (27), but simple to use [83].
Appendix H. The Incalzi Index
The Incalzi Index, developed in a retrospective way, is
performed after a multi-dimensional assessment and labora-
tory data are acquired. It includes a co-morbidity index,
based upon a scoring system that quantifies the prognostic
weight of individual diseases, and an age–co-morbidity
index, which corrects the former for the age-related increase
in death [84].References
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